Buy, hold, sell: Breville, Collins Foods, and MA Financial shares

Let's see if analysts are bullish or bearish on these names.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are a lot of ASX shares out there to choose from on the local share market.

To narrow things down, let's see what analysts are saying about the three in this article.

Are they buys, holds, or sells? Here's what the broker is recommending:

Business people discussing project on digital tablet.

Image source: Getty Images

Breville Group Ltd (ASX: BRG)

Ord Minnett is very positive on this appliance manufacturer and is recommending it to clients. The broker recently upgraded its shares to a buy rating with a $37.20 price target.

It highlights that Breville is well-placed to benefit from a consolidation of vendors by Best Buy (NYSE: BBY) in the United States. It explains:

The consolidation of vendors by Best Buy is described by Breville management as a "material change" to the retail channel structure in the US. The brands chosen benefit from additional shelf space and a structural lock-in, while the brands that have been de-ranged lose access to more than 1,000 retail locations. This dynamic is also playing out across other Best Buy categories, not just small domestic appliances.

As a primary partner in Best Buy's consolidated vendor strategy, this should provide Breville with a significant competitive advantage in the giant US market. Following recent weakness in the Breville share price, we upgrade to Buy from Accumulate with an unchanged price target of $37.20.

Collins Foods Ltd (ASX: CKF)

The broker has also been looking at quick service restaurant operator Collins Foods.

It highlights that the company is expanding its footprint in Germany with an acquisition.

However, while it sees positives, it isn't enough for anything more than a hold rating with a $12.00 price target. It explains:

Collins noted same-store sales (SSS) growth in its dominant Australian division was 2.7% in FY26-to-date but had accelerated in the second half of FY26 to 3.2%. Post the trading update, Ord Minnet trimmed its FY26 EPS estimate by 0.7%, while our forecasts for FY27 and FY28 increased by 7.2% and 8.4%, respectively, which led us to raise our target price to $12.00 from $10.50.

There is value apparent in Collins, but the company needs to exhibit a sustained period of performance in the German market, which the company is touting as its next 'growth pillar', before we can become more constructive on the stock.

MA Financial Group Ltd (ASX: MAF)

Ord Minnett is feeling bullish about this global alternative asset manager and has named it as a buy with a $10.05 price target.

It highlights that the asset management business is experiencing strong momentum and believes it is well-placed to grow its assets under management. It commented:

‍Ord Minnett has resumed coverage of MA Financial with a Buy recommendation and a target price of $10.05. Its asset management business is seeing continuing momentum in net flows and the launch of new investment vehicles in FY25 leads us to expect strong growth in assets under management (AUM) in the near term.

Further, the residential lending business is hitting its straps and will deliver a more material profit contribution in FY26. We see an attractive value proposition in MA Financial, with the stock trading on a one-year forward price-to-earnings (P/E) multiple of 14.7x, along with a forecast EPS compound annual growth rate (CAGR) of 23% over the FY25–28 horizon.

Motley Fool contributor James Mickleboro has positions in Collins Foods. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Best Buy. The Motley Fool Australia has recommended Collins Foods and Ma Financial Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Buy, hold, sell: Endeavour, Magellan, and Rio Tinto shares

The team at Morgans has been running the rule over these shares recently.

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Broker Notes

Should you buy Coles, Light & Wonder, and TPG Telecom shares in April?

Let's see if the team at Morgans rates these shares as buys ahead of the new month.

Read more »

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Broker Notes

Buy, hold, sell: Northern Star, Telix, and Virgin Australia shares

Let’s see if they are bullish or bearish on these names.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Forget CBA shares and buy this ASX ETF: experts

Here's what experts are saying about these two investment options.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Buy, hold, sell: BHP, Guzman Y Gomez, and Pro Medicus shares

Are brokers bullish or bearish on these names? Let's find out.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Humanoid robot analysing the stock market, symbolising artificial intelligence shares.
Broker Notes

Up 109% since November, are Appen shares still a buy today?

A leading expert digs into the outlook for Appen shares amid the rise of AI.

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 reasons to buy Pro Medicus shares today

Two leading investment analysts believe Pro Medicus shares are primed for a rebound.

Read more »